Local injections of OK432 can help the infiltration of adoptively transferred CD8+ T cells into the tumor sites and synergistically induce the local production of Th1-type cytokines and CXC3 chemokines

Cancer Immunology Immunotherapy

Volumn 49, Issue 7, 2000, Pages 361-368

  Tatsugami, Katsunori ^a   Tamada, Koji ^a   Abe, Koichiro ^a   Harada, Mamoru ^a   Nomoto, Kikuo ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Adoptive immunotherapy; CXC3 chemokines; OK432; Th1 type cytokines; Tumor infiltrating lymphocytes

Indexed keywords

ALPHA CHEMOKINE; CYTOKINE; MESSENGER RNA; PICIBANIL;

ADOPTIVE IMMUNOTHERAPY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; FEMALE; GENE EXPRESSION; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TUMOR GROWTH;

EID: 0033861673     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002620000131     Document Type: Article

References (44)

1. Chemokines and leukocyte traffic
2. + tumor-infiltrating lymphocytes
3. In vivo trafficking of adoptively transferred interleukin-2 expanded tumor-infiltrating lymphocytes and peripheral blood lymphocytes. Results of a double gene marking trial
4. Reduced tumorigenicity and augmented leukocyte infiltration after monocyte chemotactic protein-3 (MCP-3) gene transfer: Perivascular accumulation of dendritic cells in peritumoral tissue and neutrophil recruitment within the tumor
5. In vitro and in vivo antitumor properties of a T-cell clone generated from routine tumor-infiltrating lymphocytes
6. Streptococcal preparation OK-432 is a potent inducer of IL-12 and a T helper cell 1 dominant state
7. Obligatory role of IFN-gamma in induction of lymphokine-activated and T lymphocyte killer activity, but not in boosting of natural cytotoxicity
8. Adoptive T cell therapy of tumors: Mechanisms operative in the recognition and elimination of tumor cells
9. + T-cell response in gut-associated lymphoid tissue (GALT) of specific-pathogen-free mice
10. Homing receptors and the control of lymphocyte migration
11. Studies on the immunopotentiating effects of a streptococcal preparation, OK-432. I. Enhancement of T cell-mediated immune responses of mice
12. The past, the present and future of the OK-432 therapy for patients with malignant effusions
13. + T lymphocytes generated by local immunotherapy
14. Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection
15. Transforming growth factor beta 1 (TGF-beta 1) produced in tumour tissue after chemotherapy acts as a lymphokin activated killer attractant
16. Human Mig chemokine: Biochemical and functional characterization
17. Chemokine receptor specific for IP10 and mig: Structure, function, and expression in activated T-lymphocytes
18. IP-10, a -C-X-C- chemokine, elicits a potent thymus-dependent antitumor response in vivo
19. IL-2 and IFN-gamma are two necessary lymphokines in the development of cytolytic T cells
20. Lymphocyte responses to chemokines
21. Enhanced induction of very late antigen 4/lymphocyte function-associated antigen 1-dependent T-cell migration to tumor sites following administration of interleukin 12
22. Local injection of OK432 can augment the TH1-type T-cell response in tumor-draining lymph node cells and increase their immunotherapeutical potential
23. The role of chemokines in inflammation
24. T cell costimulation by B7/BB1 induces CD8 T cell-dependent tumor rejection: An important role of B7/BB1 in the induction, recruitment, and effector function of antitumor T cells
25. Activated macrophages are responsible for the tumor-inhibitory effect in mice receiving intravenous injection of OK-432
26. Interferon-inducible protein-10 identified as a mediator of tumor necrosis in vivo
27. Mig, the monokine induced by interferon-gamma, promotes tumor necrosis in vivo
28. Evaluation of prognoses of patients with gastric cancer by the responsiveness of peripheral blood lymphocyte to OK432 in vitro
29. Stimulation of tumor-draining lymph node cells with superantigenic staphylococcal toxins leads to the generation of tumor-specific effector T cells
30. Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm
31. Role of C-X-C chemokines as regulators of angiogenesis in lung cancer
32. The functional role of the ELR motif in CXC chemokine-mediated angiogenesis
33. Recombinant human tumor necrosis factor-alpha: Effects on proliferation of normal and transformed cells in vitro
34. The preclinical screening laboratory: Evaluation of immunomodulatory and therapeutic properties of biological response modifiers
35. + T cells
36. Intratumoral injection of a streptococcal preparation, OK-432, before surgery for gastric cancer. A randomized trial
37. Cytokine and chemokine expression in tumors of mice receiving systemic therapy with IL-12
38. Direct cytolysis by partially-purified preparations of immune interferon
39. Intrapleural administration of OK432 in cancer patients: Augmentation of autologous tumor killing activity of tumor-associated large granular lymphocytes
40. Activation of cytotoxic polymorphonuclear leukocytes by in vivo administration of a streptococcal preparation, OK-432
41. Clinical value of immunotherapy with the streptococcal preparation OK-432 in non-small cell lung cancer
42. Modulation of murine tumor major histocompatibility antigens by cytokines in vivo and in vitro
43. B7-negative versus B7-positive P815 tumor: Differential requirements for priming of an antitumor immune response in lymph nodes
44. Novel lymphocyte-specific CC chemokines and their receptors